AmerisourceBergen Corp. (NYSE:ABC) saw a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 6,840,000 shares, a decline of 7.4% from the January 15th total of 7,390,000 shares. Currently, 4.6% of the company’s stock are short sold. Based on an average daily trading volume, of 1,100,000 shares, the short-interest ratio is currently 6.2 days.
ABC opened at $94.36 on Friday. The business has a 50 day moving average price of $88.42 and a two-hundred day moving average price of $86.41. The company has a quick ratio of 0.56, a current ratio of 0.95 and a debt-to-equity ratio of 1.18. The company has a market cap of $19.46 billion, a PE ratio of 30.54, a P/E/G ratio of 1.66 and a beta of 1.01. AmerisourceBergen has a 52 week low of $70.55 and a 52 week high of $97.50.
AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings data on Thursday, January 30th. The company reported $1.76 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.67 by $0.09. The firm had revenue of $47.86 billion during the quarter, compared to the consensus estimate of $47.84 billion. AmerisourceBergen had a return on equity of 49.95% and a net margin of 0.36%. The firm’s revenue was up 5.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.60 EPS. As a group, sell-side analysts expect that AmerisourceBergen will post 7.69 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 14th will be paid a dividend of $0.42 per share. The ex-dividend date of this dividend is Thursday, February 13th. This is an increase from AmerisourceBergen’s previous quarterly dividend of $0.40. This represents a $1.68 annualized dividend and a yield of 1.78%. AmerisourceBergen’s dividend payout ratio is currently 23.70%.
ABC has been the subject of several research reports. Barclays reissued a “hold” rating and issued a $100.00 target price on shares of AmerisourceBergen in a report on Sunday, January 19th. Deutsche Bank boosted their target price on AmerisourceBergen from $79.00 to $93.00 and gave the company a “hold” rating in a report on Friday, January 31st. TheStreet raised AmerisourceBergen from a “c+” rating to a “b-” rating in a report on Friday, December 6th. ValuEngine downgraded AmerisourceBergen from a “hold” rating to a “sell” rating in a report on Friday, November 1st. Finally, Robert W. Baird raised AmerisourceBergen from a “neutral” rating to an “outperform” rating and set a $112.00 target price for the company in a report on Friday, February 7th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and five have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $95.13.
In other news, EVP Gina Clark sold 10,917 shares of the business’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $88.24, for a total value of $963,316.08. Also, CEO Steven H. Collis sold 19,905 shares of the business’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $93.20, for a total value of $1,855,146.00. Following the completion of the sale, the chief executive officer now directly owns 162,027 shares of the company’s stock, valued at $15,100,916.40. The disclosure for this sale can be found here. Insiders have sold a total of 64,417 shares of company stock valued at $5,743,456 over the last ninety days. 28.30% of the stock is owned by company insiders.
Institutional investors and hedge funds have recently bought and sold shares of the business. Captrust Financial Advisors increased its position in AmerisourceBergen by 917.6% during the 4th quarter. Captrust Financial Advisors now owns 5,271 shares of the company’s stock worth $448,000 after purchasing an additional 4,753 shares during the period. Cubist Systematic Strategies LLC increased its position in AmerisourceBergen by 79.5% during the 4th quarter. Cubist Systematic Strategies LLC now owns 30,672 shares of the company’s stock worth $2,608,000 after purchasing an additional 13,582 shares during the period. AQR Capital Management LLC increased its position in AmerisourceBergen by 117.3% during the 4th quarter. AQR Capital Management LLC now owns 858,551 shares of the company’s stock worth $72,230,000 after purchasing an additional 463,487 shares during the period. Caisse DE Depot ET Placement DU Quebec increased its position in AmerisourceBergen by 23.6% during the 4th quarter. Caisse DE Depot ET Placement DU Quebec now owns 204,100 shares of the company’s stock worth $17,353,000 after purchasing an additional 39,000 shares during the period. Finally, Oracle Investment Management Inc. acquired a new position in AmerisourceBergen during the 4th quarter worth approximately $2,126,000. 66.80% of the stock is owned by hedge funds and other institutional investors.
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.
Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.